의료용 미생물 검사 기술 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
Medical Microbiology Testing Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1487521
리서치사:Transparency Market Research
발행일:2024년 04월
페이지 정보:영문 210 Pages
라이선스 & 가격 (부가세 별도)
한글목차
의료용 미생물 검사 기술 시장 - 조사 범위
TMR의 조사 보고서 "세계 의료용 미생물 검사 기술 시장"은 2024년부터 2034년까지 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하고 2024년을 기준 연도로, 2034년을 예측 연도로 삼았다, 2018년부터 2034년까지 세계 의료용 미생물 검사 기술 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 의료용 미생물 검사 기술 시장의 연평균 복합 성장률(CAGR%)도 제공합니다.
이 보고서는 광범위한 1차 조사, KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체와의 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조한 2차 조사를 통해 의료용 미생물 검사 기술 시장을 이해하고자 작성되었습니다. 시장을 파악했습니다.
시장 현황
2023년 시장 규모
42억 달러
2034년 시장 가치
104억 달러
CAGR
8.6%
이 보고서는 세계 의료용 미생물 검사 기술 시장 경쟁 구도를 심층적으로 분석합니다. 세계 의료용 미생물 검사 기술 시장에서 사업을 운영하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향 및 SWOT는 이 보고서에서 소개하는 세계 의료 미생물 검사 기술 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
시장 개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19 팬데믹의 산업에 대한 영향
제6장 세계 시장 분석과 예측 : 적응증별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 적응증별, 2020년-2034년
호흡기질환
신경질환
감염증
기타
시장의 매력 : 적응증별
제7장 세계 시장 분석과 예측 : 기술별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 기술별, 2020년-2034년
세포배양
현미경 검사
혈청학
시장의 매력 : 기술별
제8장 세계 시장 분석과 예측 : 용도별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 용도별, 2020년-2034년
진단
치료 모니터링
시장의 매력 : 용도별
제9장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 최종사용자별, 2020년-2034년
병원실험실
병리실험실
연구기관
기타
시장의 매력 : 최종사용자별
제10장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2020년-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 경쟁 매트릭스(기업 Tier별, 기업 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
Abbott Laboratories
Agilent Technologies
Beckman Coulter, Inc.(a Danaher segment)
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMerieux
F. Hoffmann-La Roche Ltd.
HiMedia Laboratories Private Limited
Hologic Inc.
Thermo Fisher Scientific
LSH
영문 목차
영문목차
Medical Microbiology Testing Technologies Market - Scope of Report
TMR's report on the global medical microbiology testing technologies market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global medical microbiology testing technologies market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical microbiology testing technologies market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the medical microbiology testing technologies market.
Market Snapshot
Market Value in 2023
US$ 4.2 Bn
Market Value in 2034
US$ 10.4 Bn
CAGR
8.6%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical microbiology testing technologies market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global medical microbiology testing technologies market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical microbiology testing technologies market.
The report delves into the competitive landscape of the global medical microbiology testing technologies market. Key players operating in the global medical microbiology testing technologies market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global medical microbiology testing technologies market profiled in this report.
Key Questions Answered in Global medical microbiology testing technologies Market Report:
What is the sales/revenue generated by medical microbiology testing technologies across all regions during the forecast period?
What are the opportunities in the global medical microbiology testing technologies market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Medical Microbiology Testing Technologies Market - Research Objectives and Research Approach
The comprehensive report on the global medical microbiology testing technologies market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global medical microbiology testing technologies market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global medical microbiology testing technologies market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Microbiology Testing Technologies Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by Indication
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Indication, 2020-2034
6.3.1. Respiratory Diseases
6.3.2. Neurological Diseases
6.3.3. Infectious Diseases
6.3.4. Others
6.4. Market Attractiveness, by Indication
7. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2034
7.3.1. Cell Culture
7.3.2. Microscopy
7.3.3. Serology
7.4. Market Attractiveness, by Technology
8. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Diagnostic
8.3.2. Treatment Monitoring
8.4. Market Attractiveness, by Application
9. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospital Labs
9.3.2. Pathology Labs
9.3.3. Research Institutes
9.3.4. Others
9.4. Market Attractiveness, by End-user
10. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Medical Microbiology Testing Technologies Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Indication, 2020-2034
11.2.1. Respiratory Diseases
11.2.2. Neurological Diseases
11.2.3. Infectious Diseases
11.2.4. Others
11.3. Market Attractiveness, by Indication
11.4. Market Value Forecast, by Technology, 2020-2034
11.4.1. Cell Culture
11.4.2. Microscopy
11.4.3. Serology
11.5. Market Attractiveness, by Technology
11.6. Market Value Forecast, by Application, 2020-2034
11.6.1. Diagnostic
11.6.2. Treatment Monitoring
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospital Labs
11.8.2. Pathology Labs
11.8.3. Research Institutes
11.8.4. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Indication
11.11.2. By Technology
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Medical Microbiology Testing Technologies Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Indication, 2020-2034
12.2.1. Respiratory Diseases
12.2.2. Neurological Diseases
12.2.3. Infectious Diseases
12.2.4. Others
12.3. Market Attractiveness, by Indication
12.4. Market Value Forecast, by Technology, 2020-2034
12.4.1. Cell Culture
12.4.2. Microscopy
12.4.3. Serology
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, by Application, 2020-2034
12.6.1. Diagnostic
12.6.2. Treatment Monitoring
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospital Labs
12.8.2. Pathology Labs
12.8.3. Research Institutes
12.8.4. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Indication
12.11.2. By Technology
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Medical Microbiology Testing Technologies Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Indication, 2020-2034
13.2.1. Respiratory Diseases
13.2.2. Neurological Diseases
13.2.3. Infectious Diseases
13.2.4. Others
13.3. Market Attractiveness, by Indication
13.4. Market Value Forecast, by Technology, 2020-2034
13.4.1. Cell Culture
13.4.2. Microscopy
13.4.3. Serology
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, by Application, 2020-2034
13.6.1. Diagnostic
13.6.2. Treatment Monitoring
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospital Labs
13.8.2. Pathology Labs
13.8.3. Research Institutes
13.8.4. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Indication
13.11.2. By Technology
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Medical Microbiology Testing Technologies Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Indication, 2020-2034
14.2.1. Respiratory Diseases
14.2.2. Neurological Diseases
14.2.3. Infectious Diseases
14.2.4. Others
14.3. Market Attractiveness, by Indication
14.4. Market Value Forecast, by Technology, 2020-2034
14.4.1. Cell Culture
14.4.2. Microscopy
14.4.3. Serology
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, by Application, 2020-2034
14.6.1. Diagnostic
14.6.2. Treatment Monitoring
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospital Labs
14.8.2. Pathology Labs
14.8.3. Research Institutes
14.8.4. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Indication
14.11.2. By Technology
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Medical Microbiology Testing Technologies Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Indication, 2020-2034
15.2.1. Respiratory Diseases
15.2.2. Neurological Diseases
15.2.3. Infectious Diseases
15.2.4. Others
15.3. Market Attractiveness, by Indication
15.4. Market Value Forecast, by Technology, 2020-2034
15.4.1. Cell Culture
15.4.2. Microscopy
15.4.3. Serology
15.5. Market Attractiveness, by Technology
15.6. Market Value Forecast, by Application, 2020-2034
15.6.1. Diagnostic
15.6.2. Treatment Monitoring
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospital Labs
15.8.2. Pathology Labs
15.8.3. Research Institutes
15.8.4. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Indication
15.11.2. By Technology
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Agilent Technologies
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Beckman Coulter, Inc. (a Danaher segment)
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Becton, Dickinson and Company
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Bio-Rad Laboratories, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. bioMerieux
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. F. Hoffmann-La Roche Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. HiMedia Laboratories Private Limited
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Hologic Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Thermo Fisher Scientific
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
